Company Profile: Kenvue Inc. (KVUE)
KVUE insider trades (13 months) →$19.31 −1.28% vs. previous close · Market cap $37.11B
Market and Valuation
Price & Market
52-Week Range
Volume
Valuation Multiples
Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Dividends
Valuation Context
P/E vs sector (indicative)
Loading historical OHLCV database...
Financial Statements TTM (Trailing 12 Months)
Income Statement
Margins
Per Share
Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Balance Sheet & Liquidity
Cash Flows
Profitability
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.
Growth and Margins
Per Share
Cash Flows (TTM)
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
| Quarter | Period | Actual EPS | Estimated EPS | Difference | Surprise % | Currency |
|---|
Ownership Structure
Ownership Distribution
Shares & Short Interest
Governance Score (1=Best, 10=Worst)
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
| Organization | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
| Fund | Report Date | % Shares | No. Shares | Value (USD) | Change % |
|---|
Recent Insider Trades
| Executive / Insider | Title | Date | Action | Shares |
|---|
Options Chain
CALLS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
PUTS
| Strike | Last | Bid | Ask | Vol. | O.I. | IV |
|---|
Kenvue Inc. (KVUE) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
| Type | Date | Official link |
|---|---|---|
| 25-NSE | 2026-11-02 | View filing ↗ |
| 8-K | 2026-10-30 | View filing ↗ |
| 8-K | 2026-10-13 | View filing ↗ |
| 10-Q | 2026-08-06 | View filing ↗ |
| SD | 2026-05-28 | View filing ↗ |
| 8-K | 2026-05-22 | View filing ↗ |
| 10-Q | 2026-05-07 | View filing ↗ |
| 8-K | 2026-04-15 | View filing ↗ |
| DEFA14A | 2026-04-08 | View filing ↗ |
| 10-K | 2026-02-20 | View filing ↗ |
Company and Executive Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
General Information
Key Executives
| Name | Title | Age | Total pay |
|---|---|---|---|
| Mr. Kirk L. Perry | CEO & Director | 58 | 2.94M |
| Mr. Michael P. Wondrasch | Chief Technology & Data Officer | 56 | 1.02M |
| Mr. Matthew Orlando | General Counsel | 48 | 1.25M |
| Mr. Carlton Lawson | Group President of Europe, Middle East & Africa | 56 | 1.41M |
| Ms. Heather R. Howlett | Interim CFO & Chief Accounting Officer | 47 | - |
| Ms. Meredith Stevens | Chief Operations Officer | 62 | 1.83M |
| Dr. Caroline Tillett Ph.D. | Chief Scientific Officer | 53 | - |
| Mr. Jonathan Halvorson | Chief Digital & Marketing Officer | 42 | - |
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.